Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Maximum (mean±SD) substrate velocity (mm/s, logarithmic scale) of disruptive signal (DN) recorded in the frequency range 50-300 Hz from potted plants in semi-field conditions and f... by Anna Eriksson (176834)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…(<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

Number of Doppler examinations (i.e., 1, 2, or 3) that allowed the board-certified specialist (VC) in charge of the French cardiovascular breed screening program (2010–2023) to con... by Valérie Chetboul (579758)

Human Milk Oligosaccharide Lacto‑<i>N</i>‑Neotetraose Promotes Gut Microbiota Recovery in the Context of Antibiotic-Induced Dysbiosis by Jiaman Pang (11404950)

Gene Ontology network analysis of differentially-enriched Vpu-proximal protein subsets. by Charlotte A. Stoneham (10819125)

The effect of α-MSH treatment on the immunostaining of tight juntion proteins claudin-4 and ZO-1 in cytokine treated Caco-2 cells. by Judit Váradi (507449)

<i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays. by Ling Tian (107492)

PRISMA flow diagram. by Apoorva Anand (17921197)

Subjects:

Meta-analyses of COVIDST diagnostic accuracy. by Apoorva Anand (17921197)

Subjects:

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Rg3 decreases HDAC3 expression. by Xiu Shan (62157)

TgCRT is a functional transporter and its transport efficiency is correlated with VAC size in the parasites. by L. Brock Thornton (6808385)

Area estimates in CAKR by percentage of the mean LSR of the 3000–4000 m distance class (41.9) according to the posterior predictions model. by Peter N. Neitlich (4034300)

Subjects:

Klotho decreased the expression of CHOP in mouse heart. by Shuang Song (457799)

Viral productivity decreases following heat shock. by Christine M. Livingston (370019)

Calpeptin treatment decreases cell density and proliferation. by Daniela M. Santos (211055)

Diabetic kidney shows decreased klotho expression. by Jeong Suk Kang (7359572)

“…<p>(a) Representative images of the kidney from normal and diabetic biopsies showing the decreased klotho expression in diabetic podocytes by IHC. …”